ASCUS and AGUS criteria

IAC task force summary

Diane Solomon, William J. Frable, G. Peter Vooijs, David C. Wilbur, N. Sreedevi Amma, Robert John Collins, Diane D. Davey, Bryan Kenyon Knight, Ronald D. Luff, Alexander Meisels, James Navin, Dorothy Rosenthal, Torill Sauer, Mark Stoler, Harry Z. Suprun, Kazuhiro Yamauchi

Research output: Contribution to journalArticle

Abstract

Issues: The conference participants addressed the following issues: (1) reporting of equivocal diagnoses, (2) strategies to minimize the use of such diagnoses, (3) morphologic criteria, and (4) management of women with equivocal diagnoses. Consensus Position: Equivocal diagnoses should be minimized, to the extent possible, by emphasizing cytologist education and training, improved specimen collection and quality assurance monitoring of individual and laboratory diagnosis rates. Cases fulfilling criteria for other diagnostic entities should not be included in the equivocal category. Regardless of the term utilized, an equivocal diagnosis should be qualified in some manner to indicate that the diagnosis defines a patient at increased risk of a lesion, particularly for those cases which raise concern about a possible high grade lesion. Qualification of an equivocal diagnosis can also be accomplished by appending laboratory statistics of the likelihood of various clinical outcomes or recommendations for patient follow-up. In contrast to favoring a reactive process versus squamous intraepithelial lesion (SIL), a more rationale approach to qualification of atypical squamous cells of undetermined significance may be to separate cases equivocal for low grade SIL from those suspicious for high grade SIL. With regard to glandular lesions, the conference participants expressed unanimous support for the separation of adenocarcinoma in situ (AIS) from atypical endocervical cells of undetermined significance when sufficient criteria are present. However, the diagnosis of a precursor lesion to AIS, endocervical glandular dysplasia, was controversial. The majority of conference participants discourage the use of such terms as mild glandular dysplasia and low grade glandular dysplasia for cytologic diagnoses. Ongoing Issues: Conference participants agreed that a term reflecting diagnostic uncertainty is necessary to communicate findings that are equivocal. However, participants could not agree on the wording of such a term. Opinions differed as to: (1) use of atypical, abnormal or morphologic changes to describe cell changes, (2) whether the diagnosis should indicate a squamous or glandular origin of the cells in question when this determination can be made, and (3) the value of defining morphologic criteria for such a diagnosis. The debate over terminology, as well as morphologic criteria, is ongoing, and the readership is invited to communicate opinions to Acta Cytologica. Management of women with equivocal diagnoses varies widely from locale to locale and may differ based on how the equivocal diagnosis is qualified. Findings insufficient for the diagnosis of a high grade lesion may warrant more aggressive follow-up than cases equivocal for a low grade lesion. Where sensitivity of detection of lesions is of paramount importance, follow-up will generally consist of more frequent cytology screening or colposcopy and biopsy. However, in some countries it is considered unethical to have a high percentage of false positive diagnoses, which result in overtreatment and an unnecessary burden for women participating in cervical screening. Future studies may provide a morphologic, or perhaps molecular, basis for distinguishing true precursors of neoplasia from minor lesions of no significant clinical import; this would allow a more coherent and rational approach to diagnosis and management of women with equivocal cytologic findings.

Original languageEnglish (US)
Pages (from-to)16-24
Number of pages9
JournalActa Cytologica
Volume42
Issue number1
StatePublished - 1998
Externally publishedYes

Fingerprint

Advisory Committees
Atypical Squamous Cells of the Cervix
Specimen Handling
Colposcopy
Clinical Laboratory Techniques
Terminology
Uncertainty
Cell Biology

Keywords

  • Cervical smears
  • Cervix neoplasms
  • Mass screening

ASJC Scopus subject areas

  • Anatomy
  • Cell Biology
  • Histology

Cite this

Solomon, D., Frable, W. J., Vooijs, G. P., Wilbur, D. C., Amma, N. S., Collins, R. J., ... Yamauchi, K. (1998). ASCUS and AGUS criteria: IAC task force summary. Acta Cytologica, 42(1), 16-24.

ASCUS and AGUS criteria : IAC task force summary. / Solomon, Diane; Frable, William J.; Vooijs, G. Peter; Wilbur, David C.; Amma, N. Sreedevi; Collins, Robert John; Davey, Diane D.; Knight, Bryan Kenyon; Luff, Ronald D.; Meisels, Alexander; Navin, James; Rosenthal, Dorothy; Sauer, Torill; Stoler, Mark; Suprun, Harry Z.; Yamauchi, Kazuhiro.

In: Acta Cytologica, Vol. 42, No. 1, 1998, p. 16-24.

Research output: Contribution to journalArticle

Solomon, D, Frable, WJ, Vooijs, GP, Wilbur, DC, Amma, NS, Collins, RJ, Davey, DD, Knight, BK, Luff, RD, Meisels, A, Navin, J, Rosenthal, D, Sauer, T, Stoler, M, Suprun, HZ & Yamauchi, K 1998, 'ASCUS and AGUS criteria: IAC task force summary', Acta Cytologica, vol. 42, no. 1, pp. 16-24.
Solomon D, Frable WJ, Vooijs GP, Wilbur DC, Amma NS, Collins RJ et al. ASCUS and AGUS criteria: IAC task force summary. Acta Cytologica. 1998;42(1):16-24.
Solomon, Diane ; Frable, William J. ; Vooijs, G. Peter ; Wilbur, David C. ; Amma, N. Sreedevi ; Collins, Robert John ; Davey, Diane D. ; Knight, Bryan Kenyon ; Luff, Ronald D. ; Meisels, Alexander ; Navin, James ; Rosenthal, Dorothy ; Sauer, Torill ; Stoler, Mark ; Suprun, Harry Z. ; Yamauchi, Kazuhiro. / ASCUS and AGUS criteria : IAC task force summary. In: Acta Cytologica. 1998 ; Vol. 42, No. 1. pp. 16-24.
@article{67b007d05f3d4860b5f6e45b629b7d76,
title = "ASCUS and AGUS criteria: IAC task force summary",
abstract = "Issues: The conference participants addressed the following issues: (1) reporting of equivocal diagnoses, (2) strategies to minimize the use of such diagnoses, (3) morphologic criteria, and (4) management of women with equivocal diagnoses. Consensus Position: Equivocal diagnoses should be minimized, to the extent possible, by emphasizing cytologist education and training, improved specimen collection and quality assurance monitoring of individual and laboratory diagnosis rates. Cases fulfilling criteria for other diagnostic entities should not be included in the equivocal category. Regardless of the term utilized, an equivocal diagnosis should be qualified in some manner to indicate that the diagnosis defines a patient at increased risk of a lesion, particularly for those cases which raise concern about a possible high grade lesion. Qualification of an equivocal diagnosis can also be accomplished by appending laboratory statistics of the likelihood of various clinical outcomes or recommendations for patient follow-up. In contrast to favoring a reactive process versus squamous intraepithelial lesion (SIL), a more rationale approach to qualification of atypical squamous cells of undetermined significance may be to separate cases equivocal for low grade SIL from those suspicious for high grade SIL. With regard to glandular lesions, the conference participants expressed unanimous support for the separation of adenocarcinoma in situ (AIS) from atypical endocervical cells of undetermined significance when sufficient criteria are present. However, the diagnosis of a precursor lesion to AIS, endocervical glandular dysplasia, was controversial. The majority of conference participants discourage the use of such terms as mild glandular dysplasia and low grade glandular dysplasia for cytologic diagnoses. Ongoing Issues: Conference participants agreed that a term reflecting diagnostic uncertainty is necessary to communicate findings that are equivocal. However, participants could not agree on the wording of such a term. Opinions differed as to: (1) use of atypical, abnormal or morphologic changes to describe cell changes, (2) whether the diagnosis should indicate a squamous or glandular origin of the cells in question when this determination can be made, and (3) the value of defining morphologic criteria for such a diagnosis. The debate over terminology, as well as morphologic criteria, is ongoing, and the readership is invited to communicate opinions to Acta Cytologica. Management of women with equivocal diagnoses varies widely from locale to locale and may differ based on how the equivocal diagnosis is qualified. Findings insufficient for the diagnosis of a high grade lesion may warrant more aggressive follow-up than cases equivocal for a low grade lesion. Where sensitivity of detection of lesions is of paramount importance, follow-up will generally consist of more frequent cytology screening or colposcopy and biopsy. However, in some countries it is considered unethical to have a high percentage of false positive diagnoses, which result in overtreatment and an unnecessary burden for women participating in cervical screening. Future studies may provide a morphologic, or perhaps molecular, basis for distinguishing true precursors of neoplasia from minor lesions of no significant clinical import; this would allow a more coherent and rational approach to diagnosis and management of women with equivocal cytologic findings.",
keywords = "Cervical smears, Cervix neoplasms, Mass screening",
author = "Diane Solomon and Frable, {William J.} and Vooijs, {G. Peter} and Wilbur, {David C.} and Amma, {N. Sreedevi} and Collins, {Robert John} and Davey, {Diane D.} and Knight, {Bryan Kenyon} and Luff, {Ronald D.} and Alexander Meisels and James Navin and Dorothy Rosenthal and Torill Sauer and Mark Stoler and Suprun, {Harry Z.} and Kazuhiro Yamauchi",
year = "1998",
language = "English (US)",
volume = "42",
pages = "16--24",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "1",

}

TY - JOUR

T1 - ASCUS and AGUS criteria

T2 - IAC task force summary

AU - Solomon, Diane

AU - Frable, William J.

AU - Vooijs, G. Peter

AU - Wilbur, David C.

AU - Amma, N. Sreedevi

AU - Collins, Robert John

AU - Davey, Diane D.

AU - Knight, Bryan Kenyon

AU - Luff, Ronald D.

AU - Meisels, Alexander

AU - Navin, James

AU - Rosenthal, Dorothy

AU - Sauer, Torill

AU - Stoler, Mark

AU - Suprun, Harry Z.

AU - Yamauchi, Kazuhiro

PY - 1998

Y1 - 1998

N2 - Issues: The conference participants addressed the following issues: (1) reporting of equivocal diagnoses, (2) strategies to minimize the use of such diagnoses, (3) morphologic criteria, and (4) management of women with equivocal diagnoses. Consensus Position: Equivocal diagnoses should be minimized, to the extent possible, by emphasizing cytologist education and training, improved specimen collection and quality assurance monitoring of individual and laboratory diagnosis rates. Cases fulfilling criteria for other diagnostic entities should not be included in the equivocal category. Regardless of the term utilized, an equivocal diagnosis should be qualified in some manner to indicate that the diagnosis defines a patient at increased risk of a lesion, particularly for those cases which raise concern about a possible high grade lesion. Qualification of an equivocal diagnosis can also be accomplished by appending laboratory statistics of the likelihood of various clinical outcomes or recommendations for patient follow-up. In contrast to favoring a reactive process versus squamous intraepithelial lesion (SIL), a more rationale approach to qualification of atypical squamous cells of undetermined significance may be to separate cases equivocal for low grade SIL from those suspicious for high grade SIL. With regard to glandular lesions, the conference participants expressed unanimous support for the separation of adenocarcinoma in situ (AIS) from atypical endocervical cells of undetermined significance when sufficient criteria are present. However, the diagnosis of a precursor lesion to AIS, endocervical glandular dysplasia, was controversial. The majority of conference participants discourage the use of such terms as mild glandular dysplasia and low grade glandular dysplasia for cytologic diagnoses. Ongoing Issues: Conference participants agreed that a term reflecting diagnostic uncertainty is necessary to communicate findings that are equivocal. However, participants could not agree on the wording of such a term. Opinions differed as to: (1) use of atypical, abnormal or morphologic changes to describe cell changes, (2) whether the diagnosis should indicate a squamous or glandular origin of the cells in question when this determination can be made, and (3) the value of defining morphologic criteria for such a diagnosis. The debate over terminology, as well as morphologic criteria, is ongoing, and the readership is invited to communicate opinions to Acta Cytologica. Management of women with equivocal diagnoses varies widely from locale to locale and may differ based on how the equivocal diagnosis is qualified. Findings insufficient for the diagnosis of a high grade lesion may warrant more aggressive follow-up than cases equivocal for a low grade lesion. Where sensitivity of detection of lesions is of paramount importance, follow-up will generally consist of more frequent cytology screening or colposcopy and biopsy. However, in some countries it is considered unethical to have a high percentage of false positive diagnoses, which result in overtreatment and an unnecessary burden for women participating in cervical screening. Future studies may provide a morphologic, or perhaps molecular, basis for distinguishing true precursors of neoplasia from minor lesions of no significant clinical import; this would allow a more coherent and rational approach to diagnosis and management of women with equivocal cytologic findings.

AB - Issues: The conference participants addressed the following issues: (1) reporting of equivocal diagnoses, (2) strategies to minimize the use of such diagnoses, (3) morphologic criteria, and (4) management of women with equivocal diagnoses. Consensus Position: Equivocal diagnoses should be minimized, to the extent possible, by emphasizing cytologist education and training, improved specimen collection and quality assurance monitoring of individual and laboratory diagnosis rates. Cases fulfilling criteria for other diagnostic entities should not be included in the equivocal category. Regardless of the term utilized, an equivocal diagnosis should be qualified in some manner to indicate that the diagnosis defines a patient at increased risk of a lesion, particularly for those cases which raise concern about a possible high grade lesion. Qualification of an equivocal diagnosis can also be accomplished by appending laboratory statistics of the likelihood of various clinical outcomes or recommendations for patient follow-up. In contrast to favoring a reactive process versus squamous intraepithelial lesion (SIL), a more rationale approach to qualification of atypical squamous cells of undetermined significance may be to separate cases equivocal for low grade SIL from those suspicious for high grade SIL. With regard to glandular lesions, the conference participants expressed unanimous support for the separation of adenocarcinoma in situ (AIS) from atypical endocervical cells of undetermined significance when sufficient criteria are present. However, the diagnosis of a precursor lesion to AIS, endocervical glandular dysplasia, was controversial. The majority of conference participants discourage the use of such terms as mild glandular dysplasia and low grade glandular dysplasia for cytologic diagnoses. Ongoing Issues: Conference participants agreed that a term reflecting diagnostic uncertainty is necessary to communicate findings that are equivocal. However, participants could not agree on the wording of such a term. Opinions differed as to: (1) use of atypical, abnormal or morphologic changes to describe cell changes, (2) whether the diagnosis should indicate a squamous or glandular origin of the cells in question when this determination can be made, and (3) the value of defining morphologic criteria for such a diagnosis. The debate over terminology, as well as morphologic criteria, is ongoing, and the readership is invited to communicate opinions to Acta Cytologica. Management of women with equivocal diagnoses varies widely from locale to locale and may differ based on how the equivocal diagnosis is qualified. Findings insufficient for the diagnosis of a high grade lesion may warrant more aggressive follow-up than cases equivocal for a low grade lesion. Where sensitivity of detection of lesions is of paramount importance, follow-up will generally consist of more frequent cytology screening or colposcopy and biopsy. However, in some countries it is considered unethical to have a high percentage of false positive diagnoses, which result in overtreatment and an unnecessary burden for women participating in cervical screening. Future studies may provide a morphologic, or perhaps molecular, basis for distinguishing true precursors of neoplasia from minor lesions of no significant clinical import; this would allow a more coherent and rational approach to diagnosis and management of women with equivocal cytologic findings.

KW - Cervical smears

KW - Cervix neoplasms

KW - Mass screening

UR - http://www.scopus.com/inward/record.url?scp=0031933740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031933740&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 16

EP - 24

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 1

ER -